About Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is a biopharmaceutical company founded in 2015 and headquartered in Lexington, Massachusetts. The company focuses on developing and commercializing therapeutic medicines for patients with significant unmet medical needs, particularly in the areas of autoimmune and inflammatory diseases. Kiniksa is publicly traded on the NASDAQ stock exchange under the ticker symbol KNSA. The company's portfolio includes ARCALYST® (rilonacept), their first FDA-approved medicine, which is indicated for the treatment of recurrent pericarditis and other autoinflammatory conditions. Their pipeline also consists of several other drug candidates targeting various inflammatory and autoimmune conditions, including KPL-404 and mavrilimumab. Kiniksa employs a scientific approach that combines immunology and inflammation research to develop novel therapeutics. The company maintains strategic partnerships with academic institutions and other pharmaceutical companies to advance their research and development efforts. Their business model focuses on identifying, acquiring, and developing promising drug candidates through clinical trials and regulatory approval processes. The company's leadership team consists of experienced pharmaceutical industry executives with backgrounds in drug development, clinical research, and commercialization. Kiniksa continues to expand its research and development capabilities while building its commercial infrastructure to support the distribution of its approved products.
The information on this page is not an endorsement of Truv's services by Kiniksa Pharmaceuticals and is meant to be purely informational.
Verify Kiniksa Pharmaceuticals Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it's been never been easier and more streamlined to verify an employee. Learn more
Kiniksa Pharmaceuticals Employment Verification FAQs.
You can verify employment for Kiniksa Pharmaceuticals employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Kiniksa Pharmaceuticals and many other employers.
Yes, Truv offers both employment and income verification services for Kiniksa Pharmaceuticals employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Hemacare, Coopergenomics and Galactic.
No, the information provided about Truv’s verification services is not an endorsement by the Kiniksa Pharmaceuticals.
